ArticleThe Journal of dermatology2025

Clinical Characteristics and Safety Profiles of Japanese Psoriasis Patients Who Continued Apremilast Treatment for 6 and 12 Months: A Post Hoc Analysis of an Apremilast Postmarketing Surveillance Study.

Mamitaro Ohtsuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.